• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Nucleoporin Nup43 (NUP43)

ACP13645

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP13645 Target NameNUP43
Target SynonymsNUP43Nucleoporin Nup43; Nup107-160 subcomplex subunit Nup43; p42FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range1-380
Protein LengthFull length proteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8NFH3
Background Information
  • Uniprot Id

    Q8NFH3

  • Target Species

    Human

  • Target Name

    NUP43

  • Target Full Name

    Nucleoporin Nup43

  • Target Function

    Component of the Nup107-160 subcomplex of the nuclear pore complex (NPC). The Nup107-160 subcomplex is required for the assembly of a functional NPC. The Nup107-160 subcomplex is also required for normal kinetochore microtubule attachment, mitotic progression and chromosome segregation.

  • Target Subcellular Location

    Chromosome, centromere, kinetochore. Nucleus, nuclear pore complex.

  • Target Synonyms

    NUP43Nucleoporin Nup43; Nup107-160 subcomplex subunit Nup43; p42

  • Target Background

    Bidirectional transport of macromolecules between the cytoplasm and nucleus occurs through nuclear pore complexes (NPCs) embedded in the nuclear envelope. NPCs are composed of subcomplexes, and NUP43 is part of one such subcomplex, Nup107-160 (Loiodice et al., 2004 [PubMed 15146057]).

Inquire Recombinant Human Nucleoporin Nup43 (NUP43) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification